Publications by authors named "Kim Ellefsen"

Claim this Profile
P
Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis.
Louis-Emmanuel Chriqui, Etienne Abdelnour-Berchtold, Edoardo Zanfrini, Severine Devesa-Perez, Michel Gonzalez, Kim Ellefsen

Cancer Treat Res Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Richard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, David M Asmuth, Barry Peters, Kim Ellefsen

Lancet Infect Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10.
Diana Marek, Stephanie Papin, Kim Ellefsen, Julien Niederhauser, Nathalie Isidor

J Neuroinflammation· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects.
Eftyhia Vardas, Ioana Stanescu, Mika Leinonen, Kim Ellefsen, Giuseppe Pantaleo

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.
Oriol Manuel, Manuel Pascual, Katja Hoschler, Stefano Giulieri, Deolinda Alves, Kim Ellefsen

Clin Infect Dis· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.
Jacob Bukczynski, Tao Wen, Kim Ellefsen, Jack Gauldie, Tania H Watts

Proc Natl Acad Sci U S A· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development.
Alexandre Harari, Kim Ellefsen, Patrick Champagne, Massimo Nobile, Giuseppe Pantaleo

Adv Exp Med Biol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.
Kim Ellefsen, Alexandre Harari, Patrick Champagne, Pierre-Alexandre Bart, Rafick-Pierre Sékaly

Eur J Immunol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.
Alexandre Harari, G Paolo Rizzardi, Kim Ellefsen, Donatella Ciuffreda, Patrick Champagne

Blood· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.
G Paolo Rizzardi, Alexandre Harari, Brunella Capiluppi, Giuseppe Tambussi, Kim Ellefsen

J Clin Invest· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic selection generates a large T cell pool recognizing a self-peptide in humans.
Alfred Zippelius, Mikaël J Pittet, Pascal Batard, Nathalie Rufer, Magda de Smedt, Kim Ellefsen

J Exp Med· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis